Does cardiac dysfunction explain deleterious effects of beta-blockers in cirrhosis and refractory ascites?

Hepatology. 2011 Jan;53(1):370-1. doi: 10.1002/hep.23857. Epub 2010 Jul 29.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adrenergic beta-Antagonists / adverse effects*
  • Ascites / drug therapy*
  • Ascites / mortality
  • Cardiac Output / drug effects*
  • Heart Diseases / chemically induced*
  • Humans
  • Liver Cirrhosis / drug therapy*
  • Liver Cirrhosis / mortality
  • Propranolol / adverse effects*

Substances

  • Adrenergic beta-Antagonists
  • Propranolol